PrEP can reduce the risk of sexually transmitted HIV infection by 99%. Discrimination and distrust are two barriers Black gay men face in accessing this lifesaving treatment.
Academic rigour, journalistic flair
Articles on PrEP
Displaying 1 - 20 of 52 articles
Despite higher than average rates of HIV infection, Hispanic women have relatively low awareness of PrEP, an effective HIV-prevention medication.
A breakthrough drug is a significant step forward in the fight against HIV. But without changes in behaviour, infection rates won’t come down.
Funding announced in this week’s federal budget moves Australia closer to eliminating HIV.
When appropriate care is available, several studies have shown, gay Black men are more likely to test themselves for HIV and engage in less risky sexual behaviors than gay men of other races.
Two-thirds of new HIV infections are among gay and bisexual men. Although cases have decreased among white men, they have stagnated among communities of color.
Many people at heightened risk for HIV have never been tested. Those who have self-tested for HIV often don’t go on to receive care or change their sexual behavior.
On the basis of government appointment technicalities and religious freedom, Americans may lose free coverage for cancer and blood pressure screenings, HIV prevention medication and other essential services.
The next step in HIV prevention — long-acting injectable pre-exposure prophylaxis (PrEP) — is not yet available in Canada, a year after its approval in the U.S.
Dec. 1 marks World AIDS Day. Canada has the tools and means to end the epidemic. The question remains, are we up to the task?
Experts across the board have identified inequality as a major challenge to efforts to end AIDS.
The benefit of an injectable product is that it avoids the adherence issues related to taking a pill daily.
Some countries, like Kenya, Uganda, South Africa, Zambia, and Nigeria, have been more proactive than others, but it is still hard for many to get PrEP.
Judge Reed O'Connor ruled in a case that coverage for HIV prevention medicine PrEP violated the religious freedom of the plaintiffs. It is unclear whether the order will extend nationwide.
PrEP enables adolescent girls and young women to protect themselves from HIV without having to convince a partner to use a condom at the time of sex.
Adolescents and young people should get involved early in the design, planning and scale up of interventions.
This finding suggests public health efforts will have to address the treatment barriers these men face – like poverty or homophobia – to meet the nation’s goal of ending the HIV epidemic by 2030.
World AIDS Day on Dec. 1 this year comes at a time when a key step to removing financial barriers to PrEP access in the U.S. faces legal challenges.
Stigma and criminalisation of same-sex relationships makes it difficult for transgender women and men who have sex with men to seek preventive services. This compounds their risk for HIV infection.
It is urgent and overdue to implement PrEP in pregnancy and during breastfeeding. Failure to do so allows ongoing avoidable HIV infection among women in South Africa and their infants.
Job Board
-
ServiceNow Technical Lead
-
Economics Editor
-
Deputy Vice-Chancellor (Indigenous Strategy and Services)
-
Chief People & Culture Officer
-
Lecturer / Senior Lecturer in Construction and Project Management
Top contributors
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Senior lecturer, public health ethics, School of Population Health, UNSW Sydney
-
Assistant Professor of Health Law, Policy and Management, Boston University
-
Assistant Professor of Public Health, University of Iowa
-
Research Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Post-doctoral researcher, KEMRI-Wellcome Trust Research Program, Kenya Medical Research Institute
-
Lecturer in Public Health and Primary Care, Bangor University
-
Associate Professor, Public Health & Social Policy; Special Advisor Health Research, Office of the Vice-President Research and Innovation, University of Victoria
-
Associate professor in Health Psychology, University of Copenhagen
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Research Director at Donald Gordon Medical Centre, University of the Witwatersrand
-
Assistant Lecturer, University of Warwick
-
PhD candidate, Ghent University
-
Adjunct Associate Professor of Epidemiology, Columbia University
-
Clinical Ethics Fellow, Department of Family & Community Medicine, University of Toronto
